EAM
BIIB icon

Exome Asset Management’s Biogen BIIB Stock Holding History

Exome Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,317
Closed -$2.57M – 67
2024
Q3 		$2.57M Buy
+13,317
New +$2.79M 1.74% 25
2024
Q2 		– Sell
-8,200
Closed -$1.77M – 56
2024
Q1 		$1.77M Hold
8,200
– – 1.51% 27
2023
Q4 		$2.12M Buy
+8,200
New +$2.01M 2.1% 20

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Exome Asset Management's BIIB Position: Q4 2024 in Review

Exome Asset Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 13,317 shares — an estimated $2.57M sold.

Exome Asset Management first reported a position in BIIB in Q4 2023 and held it in 3 quarters. The position peaked at $2.57M in Q3 2024. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Exome Asset Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Exome Asset Management sold 13,317 Biogen shares in Q4 2024, an estimated $2.57M.
  • Exome Asset Management first reported a position in Biogen in Q4 2023 and held it in 3 quarters.
  • Exome Asset Management's Biogen position peaked at $2.57M in Q3 2024.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Exome Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.